Radiation Therapy
Treatment for Malignant neoplasm of bone and articular cartilage
Typical Dosage: 50-70 Gy in 1.8-2 Gy fractions (specific to tumor type/location)
Effectiveness
75%
Safety Score
25%
Clinical Trials
300
Participants
30K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
25
DangerousModerateSafe
Treatment Details
Dosage Range
50-70 Gy in 1.8-2 Gy fractions (specific to tumor type/location)
Time to Effect
Weeks to months (during and after treatment course)
Treatment Duration
4-8 weeks (daily fractions)
Evidence Quality
HIGHConfidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$200
Monitoring:$15,000
Side Effect Mgmt:$10,000
Total Annual:$25,200
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODQALYs Gained
3
Outcome-Based Costs
Cost per Responder
$36,000
Cost per Remission
$42,000
Radiation Therapy Outcomes
for Malignant neoplasm of bone and articular cartilage
Efficacy Outcomes
Overall Effectiveness
+75%
Response Rate
+70%
Remission Rate
+60%
Common Side Effects
Fatigue
+65%
Skin reactions (redness, peeling)
+80%
Nausea/Vomiting (if abdomen/pelvis involved)
+35%
Mucositis (if head/neck/chest involved)
+30%
Bone weakness/fracture (long term)
+15%
Secondary malignancy (long term)
+3%
Fibrosis of soft tissues (long term)
+20%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov